Oncbiomune

Developing novel cancer immunotherapy products with a proprietary vaccine technology

placeBaton Rouge, Louisiana, United States calendar_todayFounded 2005 groups16 employees language oncbiomune.com

Registered entities

Innovation

2 patent families (2 granted) — focus: Human necessities; filing pace dormant. Cited 70 times.

YearFilings
20121
20131
20151
20162
20171
20192

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%
Coming soon